1. Home
  2. ES vs BNTX Comparison

ES vs BNTX Comparison

Compare ES & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ES

Eversource Energy (D/B/A)

SELL

Current Price

$72.26

Market Cap

26.6B

Sector

Utilities

ML Signal

SELL

Logo BioNTech SE

BNTX

BioNTech SE

SELL

Current Price

$84.67

Market Cap

22.9B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ES
BNTX
Founded
1927
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.6B
22.9B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
ES
BNTX
Price
$72.26
$84.67
Analyst Decision
Hold
Buy
Analyst Count
17
21
Target Price
$72.29
★ $112.36
AVG Volume (30 Days)
★ 3.0M
944.5K
Earning Date
11-04-2026
11-03-2026
Dividend Yield
★ 4.33%
N/A
EPS Growth
★ 100.88
N/A
EPS
★ 1.75
N/A
Revenue
★ $13,547,244,000.00
N/A
Revenue This Year
$0.48
N/A
Revenue Next Year
$6.04
$0.50
P/E Ratio
$41.60
★ N/A
Revenue Growth
★ 13.83
N/A
52 Week Low
$62.72
$79.81
52 Week High
$76.57
$124.00

Technical Indicators

Market Signals
Indicator
ES
BNTX
Relative Strength Index (RSI) 64.63 38.72
Support Level $66.68 $79.81
Resistance Level $73.03 $93.48
Average True Range (ATR) 1.26 2.39
MACD 0.32 0.03
Stochastic Oscillator 86.93 7.47

Price Performance

Historical Comparison
ES
BNTX

About ES Eversource Energy (D/B/A)

Eversource Energy is a diversified holding company with subsidiaries that provide rate-regulated electricity and gas distribution service to more than 4 million customers in the Northeast US. Eversource expanded its service territories with acquisitions of NStar (2012), Aquarion (2017), and Columbia Gas (2020). In 2024 Eversource exited its 50% partnership with European utility Orsted to develop 2 gigawatts of offshore wind projects in the Northeast US. It sold Aquarion in 2026. The company exited most of its unregulated businesses in 2006.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: